These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21466441)

  • 1. Bv8-prokineticins and their receptors: modulators of pain.
    Negri L; Lattanzi R
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
    Negri L; Lattanzi R
    Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
    Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
    Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
    Negri L; Lattanzi R; Giannini E; Colucci M; Margheriti F; Melchiorri P; Vellani V; Tian H; De Felice M; Porreca F
    J Neurosci; 2006 Jun; 26(25):6716-27. PubMed ID: 16793879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulators of pain: Bv8 and prokineticins.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Curr Neuropharmacol; 2006 Jul; 4(3):207-15. PubMed ID: 18615143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8.
    Vellani V; Colucci M; Lattanzi R; Giannini E; Negri L; Melchiorri P; McNaughton PA
    J Neurosci; 2006 May; 26(19):5109-16. PubMed ID: 16687502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.
    Giannini E; Lattanzi R; Nicotra A; Campese AF; Grazioli P; Screpanti I; Balboni G; Salvadori S; Sacerdote P; Negri L
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14646-51. PubMed ID: 19667192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prokineticin system: an interface between neural inflammation and pain.
    Franchi S; Sacerdote P; Panerai A
    Neurol Sci; 2017 May; 38(Suppl 1):27-30. PubMed ID: 28527062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis.
    Negri L; Ferrara N
    Physiol Rev; 2018 Apr; 98(2):1055-1082. PubMed ID: 29537336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
    Lattanzi R; Maftei D; Negri L; Fusco I; Miele R
    Neuropeptides; 2018 Oct; 71():32-42. PubMed ID: 30253862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1.
    Maftei D; Vellani V; Artico M; Giacomoni C; Severini C; Lattanzi R
    Neuroscience; 2020 Feb; 427():16-28. PubMed ID: 31883821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
    Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
    Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle.
    Battersby S; Critchley HO; Morgan K; Millar RP; Jabbour HN
    J Clin Endocrinol Metab; 2004 May; 89(5):2463-9. PubMed ID: 15126578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Prokineticin System to Control Chronic Pain and Inflammation.
    Negri L; Maftei D
    Curr Med Chem; 2018; 25(32):3883-3894. PubMed ID: 28707588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological activity of a Bv8 analogue modified in position 24.
    Lattanzi R; Sacerdote P; Franchi S; Canestrelli M; Miele R; Barra D; Visentin S; DeNuccio C; Porreca F; De Felice M; Guida F; Luongo L; de Novellis V; Maione S; Negri L
    Br J Pharmacol; 2012 Jun; 166(3):950-63. PubMed ID: 22122547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.
    Yin TC; Mittal A; Buscaglia P; Li W; Sebag JA
    J Biol Chem; 2023 Jan; 299(1):102814. PubMed ID: 36539034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
    Boulberdaa M; Urayama K; Nebigil CG
    Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and regulation of bv8 in human blood cells.
    Zhong C; Qu X; Tan M; Meng YG; Ferrara N
    Clin Cancer Res; 2009 Apr; 15(8):2675-84. PubMed ID: 19336519
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.